03 October 2016

Change of Adviser

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it has appointed Cenkos Securities plc as its Nominated Adviser and Broker with immediate effect.

About Collagen Solutions:
Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The capabilities of the Company include the provision of native, soluble and powdered collagen formulations, processed and semi-processed tissues such as pericardium, bone, and blood vessels, and expertise in the development and contract manufacture of collagen components for use as engineered tissue scaffolds and other medical devices. These products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology. Collagen Solutions' unique offering extends beyond material supply and contract services through the highly skilled staff who support customers through the various stages of development and regulatory approval. For additional information, please visit www.collagensolutions.com.

 

Enquiries:

Collagen Solutions Plc Tel: 0141 648 9100
Jamal Rushdy, CEO
Gill Black, Chief Financial Officer  
   
Cenkos Securities plc (Nominated Adviser & Broker) Tel: 0207 397 8900
Stephen Keys  
Steve Cox  
   
Walbrook PR Ltd Tel: 020 7933 8780
Mike Wort  
Anna Dunphy